Cyclo Therapeutics
Phase 3Develops cyclodextrin-based therapies for Niemann-Pick Disease Type C and other rare diseases.
Founded
2000
Focus
Small Molecules
About
Develops cyclodextrin-based therapies for Niemann-Pick Disease Type C and other rare diseases.
Funding History
2Total raised: $30M
Series B$20MUndisclosedNov 15, 2022
Series A$10MUndisclosedJun 15, 2021
Company Info
TypePrivate
Founded2000
LocationGainesville, United States
StagePhase 3
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile